Am Heart J

1. CHRISTENSEN DM, Garred CH, Malmborg M, Sindet-Pedersen C, et al
   Clinical outcomes associated with recurrent compared to first-time myocardial infarction.
   Am Heart J. 2026 Aug 30:107592. doi: 10.1016/j.ahj.2026.107592.
   

   >> Share

   
   

   
   Am J Cardiol

2. OKOROIKE HC, Zheng W, Hasan F, Oktay A, et al
   Early Low-Density Lipoprotein Cholesterol Target Attainment Is Associated With Fewer Recurrent Cardiovascular Events After Acute Myocardial Infarction: A Real-World Cohort Study.
   Am J Cardiol. 2026 Sep 3:S0002-9149(26)00549.
   

   >> Share

   
   
3. AKBAR UA, Balla S
   Interpreting Real-World Cardiovascular Outcomes With GLP-1 Receptor Agonists.
   Am J Cardiol. 2026 Sep 2:S0002-9149(26)00543.
   

   >> Share

   
   
4. MOSEN H, Szekely A, Steding-Ehrenborg K, Akil Engblom S, et al
   Coronary Revascularization of Ischemic Territories Improves Myocardial Perfusion, Increases Submaximal Aerobic Capacity and Reduces Exercise-Induced Angina in Patients with Chronic Coronary Syndrome.
   Am J Cardiol. 2026 Aug 31:S0002-9149(26)00544.
   

   >> Share

   
   

   
   Angiology

5. AKMAN C, Guner A, Zehir R, Simsek B, et al
   Comparison of Different Side Branch Ballooning Following Provisional Stenting in Coronary Bifurcation Lesion-Related STEMI.
   Angiology. 2026;77:1151-1160.
   

   >> Share

   
   

   
   Ann Intern Med

6. ALSAARAN Z, Hill MD
   In AIS with inadequate response to tenecteplase, tirofiban vs. placebo increased excellent functional outcome rate at 90 d.
   Ann Intern Med. 2026 Sep 1. doi: 10.7326/ANNALS-26-03132.
   

   >> Share

   
   

   
   Catheter Cardiovasc Interv

7. ZHENG X
   Comparison of Radiation Dose Between Dedicated Cardiac and General-Purpose Angiography Systems in Coronary Intervention.
   Catheter Cardiovasc Interv. 2026 Jun 23. doi: 10.1002/ccd.70711.
   

   >> Share

   
   
8. GALO J, Al Qaraghuli A, Zhang C, Peleg G, et al
   Progression of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Quantitative Coronary Angiography and Quantitative Flow Ratio Analysis.
   Catheter Cardiovasc Interv. 2026 Jun 25. doi: 10.1002/ccd.70704.
   

   >> Share

   
   
9. XIONG Q, Chen S, Li W
   Delayed Anterior Interventricular Vein Opacification Guides True-Lumen Wiring in Stump-Less LAD Occlusion.
   Catheter Cardiovasc Interv. 2026;108:1094-1098.
   

   >> Share

   
   
10. GROCHE M, Silwanis C, Steinwender C, Lambert T, et al
    Consecutive Emergency Carotid Artery Stenting and Transcatheter Aortic Valve Replacement in a Patient With Cardiogenic Shock: A Case Report.
    Catheter Cardiovasc Interv. 2026 Jul 10. doi: 10.1002/ccd.70741.
    

    >> Share

    
    
11. MAGOON MJ, Ng P, Thotakura S, Stoyanov N, et al
    Electrocardiographic Changes After Percutaneous Coronary Intervention for Chronic Total Occlusion.
    Catheter Cardiovasc Interv. 2026 Jul 7. doi: 10.1002/ccd.70734.
    

    >> Share

    
    
12. MATSUMURA H, Kageyama M, Shimoji K, Waku R, et al
    Reverse Tip Detection: An IVUS-Guided Strategy for Retrograde Wire Crossing in CTO PCI.
    Catheter Cardiovasc Interv. 2026;108:1004-1008.
    

    >> Share

    
    
13. KOCHKARIAN T, Ismail A, Chaabo O, Motiwala A, et al
    Personalized Antithrombotic Therapy After Percutaneous Coronary Intervention: A Systematic Review of Risk-Stratified Approaches.
    Catheter Cardiovasc Interv. 2026 Jul 6. doi: 10.1002/ccd.70733.
    

    >> Share

    
    
14. ZWECK E, Shaw A, Polzin A, Noor N, et al
    Lower AKI Risk and Higher Survival With Microaxial Flow Pump Support During Elective PCI: A Propensity Score-Matched Study.
    Catheter Cardiovasc Interv. 2026;108:935-945.
    

    >> Share

    
    
15. ATTACHAIPANICH T, Virk HUH, Khawaja M, Alam M, et al
    Current Advances and Navigating the Complexities of SVG-PCI.
    Catheter Cardiovasc Interv. 2026;108:856-874.
    

    >> Share

    
    
16. FIROUZI A, Rad AS, Hoseini Z, Moayerifar M, et al
    A Stepwise Approach to Coronary Bifurcation Stenting: Enhancing Safety and Efficacy With Modified Jailed Balloon Techniques.
    Catheter Cardiovasc Interv. 2026;108:883-889.
    

    >> Share

    
    
17. MADDER R, Seth M, Sukul D, Gandhi S, et al
    Intracoronary Imaging to Guide PCI in Acute Coronary Syndromes: A Report From the BMC2 Registry.
    Catheter Cardiovasc Interv. 2026 Jul 6. doi: 10.1002/ccd.70723.
    

    >> Share

    
    
18. BIRGUN A, Celik MC, Karaarslan O, Yetim M, et al
    Bailout Endovascular Retrieval of a Severely Kinked Guiding Catheter During Primary PCI for Inferior STEMI.
    Catheter Cardiovasc Interv. 2026;108:844-847.
    

    >> Share

    
    
19. CASTIELLO DS, Greco F, Curcio A, Polimeni A, et al
    Mechanical Thrombus Aspiration for a Young STEMI Patient With Plaque Erosion: Time for a Stent-Free Approach?
    Catheter Cardiovasc Interv. 2026;108:833-839.
    

    >> Share

    
    
20. SAITO Y, Sangen H
    Novel Application of the Jailed Balloon Anchor Technique to Improve Guiding Catheter Stability During Intravascular Ultrasound Guided Ostial Coronary Stenting.
    Catheter Cardiovasc Interv. 2026 Jun 30. doi: 10.1002/ccd.70689.
    

    >> Share

    
    

    
    Circulation

21. SUN G, Guo X, Zhao C, Ouyang N, et al
    Long-Term Effectiveness of Intensive Blood Pressure Management Led by Nonphysician Community Healthcare Providers on Cardiovascular Events: 7-Year Follow-Up of a Cluster Randomized Trial.
    Circulation. 2026 Aug 28. doi: 10.1161/CIRCULATIONAHA.126.082511.
    

    >> Share

    
    
22. GUEDON AF, Cacoub P, Carrat F, Espitia O, et al
    Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.
    Circulation. 2026 Aug 29. doi: 10.1161/CIRCULATIONAHA.126.080365.
    

    >> Share

    
    
23. KHAN SS, Post WS
    Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Risk: From Young to Older Adulthood.
    Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.082984.
    

    >> Share

    
    
24. JEEVANATHAN J, Thomas PE, Kamstrup PR, Nordestgaard BG, et al
    Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years.
    Circulation. 2026 Aug 30. doi: 10.1161/CIRCULATIONAHA.126.079412.
    

    >> Share

    
    
25. OSERAN AS, Wadhera RK
    The Last Mile of Cardiovascular Prevention: Evidence, Access, and Policy.
    Circulation. 2026 Aug 31. doi: 10.1161/CIRCULATIONAHA.126.082918.
    

    >> Share

    
    
26. CARNETHON MR
    Searching for the Uncommon: The Future of Population Science in Cardiovascular Disease.
    Circulation. 2026;154:787-788.
    

    >> Share

    
    
27. TANAKA T, Kawakami R, Gaynor BJ, Williams D, et al
    Pathology of Genetic Variants in Spontaneous Coronary Artery Dissection.
    Circulation. 2026 Sep 1. doi: 10.1161/CIRCULATIONAHA.126.080495.
    

    >> Share

    
    
28. DEAN JL, Murphy CE, Franzos MA, Petek BJ, et al
    Cardiovascular Disease Risk Assessment in United States Military Service Members.
    Circulation. 2026 Sep 3. doi: 10.1161/CIRCULATIONAHA.126.081464.
    

    >> Share

    
    
29. DINEEN EH, Haigney MC, Levine BD, Ackerman MJ, et al
    Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association.
    Circulation. 2026 Sep 3. doi: 10.1161/CIR.0000000000001476.
    

    >> Share

    
    
30. GIUGLIANO RP, Bohula EA, Bellavia A, De Ferrari GM, et al
    Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.
    Circulation. 2026 Aug 31. doi: 10.1161/CIRCULATIONAHA.126.082436.
    

    >> Share

    
    

    
    Clin Cardiol

31. TARIQ MS, Khan RMU, Farooq AU, Raza K, et al
    Temporal Trends and Demographic Disparities in Mortality Due to Coronary Artery Disease and Hypertension in Adults Aged 25 and Above in the United States (2000 to 2024).
    Clin Cardiol. 2026;49:e70465.
    

    >> Share

    
    
32. WU T, Zhang X, Li C, Hu Y, et al
    Angiography-Based Index of Microcirculatory Resistance in Assessing the MVO and Infarct Size in STEMI Patients.
    Clin Cardiol. 2026;49:e70464.
    

    >> Share

    
    
33. NISAR S, Shah A, Perveen A
    Longitudinal Serum Uric Acid Variation and Risk of Major Adverse Cardiovascular Events and Mortality: A Systematic Review and Meta-Analysis.
    Clin Cardiol. 2026;49:e70453.
    

    >> Share

    
    

    
    Eur Heart J

34. VORA KP, Bhatt K, Doshi S, Poptani V, et al
    Intravenous dexrazoxane for haemorrhagic myocardial infarction: the SHIELD-MI study.
    Eur Heart J. 2026 Aug 31:ehag715. doi: 10.1093.
    

    >> Share

    
    
35. TARANTINI G, Zhang X, Nai Fovino L, Kan J, et al
    One vs twelve month aspirin after percutaneous coronary intervention for acute myocardial infarction: individual patient-data analysis of TARGET-FIRST and ULTIMATE-DAPT trials.
    Eur Heart J. 2026 Aug 29:ehag737. doi: 10.1093.
    

    >> Share

    
    
36. WOOD DA, Jennings CS, Kotseva K, Adamska A, et al
    ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey.
    Eur Heart J. 2026 Aug 29:ehag741. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

37. STURLEY C, Del Toro T, Batty JA, Booth E, et al
    Geographic variation in long-term health outcomes following myocardial infarction in England.
    Heart. 2026 Aug 31:heartjnl-2025-327671. doi: 10.1136/heartjnl-2025-327671.
    

    >> Share

    
    
38. ASLANGER E
    Biological uncertainty cannot be eliminated by diagnostic certainty: the Heisenberg problem of occlusive myocardial infarction.
    Heart. 2026 Aug 31:heartjnl-2026-328887. doi: 10.1136/heartjnl-2026-328887.
    

    >> Share

    
    

    
    J Am Coll Cardiol

39. MANZATO M, Kalhor P, Nogami K, Pinna A, et al
    Chronic PM(2.5) Exposure Is Associated With Invasively Assessed Coronary Endothelial Dysfunction.
    J Am Coll Cardiol. 2026;88:937-947.
    

    >> Share

    
    
40. DINEEN EH, Haigney MC, Levine BD, Ackerman MJ, et al
    Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association.
    J Am Coll Cardiol. 2026 Sep 3:S0735-1097(26)07067.
    

    >> Share

    
    
41. LI T, Sun Q, Liu Y, Long C, et al
    From Observation to Anticipation in a Changing Climate: Building a Climate-Cardiovascular Early Warning System.
    J Am Coll Cardiol. 2026;88:1030-1032.
    

    >> Share

    
    
42. DESCH S, Pugachova S, de Waha S, Thevathasan T, et al
    All-Cause Mortality Up to 20 Years After PCI or CABG for Left Main Disease.
    J Am Coll Cardiol. 2026 Aug 14:S0735-1097(26)07375.
    

    >> Share

    
    
43. OYAMA K, Takahashi J, Funaki T, Oyamada S, et al
    Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome: The BRIDGE Trial.
    J Am Coll Cardiol. 2026 Aug 31:S0735-1097(26)07509.
    

    >> Share

    
    
44. VALGIMIGLI M, Frigoli E, Landi A, Covani M, et al
    Stent Retriever Thrombectomy in Patients With Myocardial Infarction The Open-label, Multicenter NATURE Superiority trial.
    J Am Coll Cardiol. 2026 Aug 29:S0735-1097(26)07586.
    

    >> Share

    
    
45. SHARMA SP, Budde RPJ, Marc van der Zee P, Gurlek C, et al
    Addition of Computed Tomography-derived Fractional Flow Reserve in the diagnostic pathway of patients with stable coronary artery disease: the FUSION randomized controlled trial.
    J Am Coll Cardiol. 2026 Aug 28:S0735-1097(26)07589.
    

    >> Share

    
    

    
    J Clin Invest

46. SAKALLI ET, Rizzo G, Zernecke A, Campos Ramos G, et al
    Type I IFN signaling shapes subset-specific monocyte fates in the injured myocardium.
    J Clin Invest. 2026;136:e209791.
    

    >> Share

    
    
47. TAKIZAWA N, Hironaka T, Watanabe H, Suetsugu H, et al
    Branched-chain amino acid transaminase 1-mediated pathway promotes proline-dependent collagen production in cardiac myofibroblasts.
    J Clin Invest. 2026;136:e182216.
    

    >> Share

    
    

    
    J Electrocardiol

48. FRICK WH, Smith SW
    The illusion of simplicity: Diagnostic inconsistencies within the STEMI paradigm.
    J Electrocardiol. 2026;98:154392.
    

    >> Share

    
    
49. KNUDSEN A, Struijk JJ, Riahi S, Hasselbalch RB, et al
    Prediction of Elevated Troponin T Levels from Prehospital Electrocardiograms.
    J Electrocardiol. 2026;98:154391.
    

    >> Share

    
    
50. TOMCSANYI J, Kollar L, Csakanyi M
    New subtle anterior Q-wave and LAD occlusion.
    J Electrocardiol. 2026;98:154398.
    

    >> Share

    
    
51. ZHANG H, Ma J, Ye S, Shan C, et al
    Transient pseudo-P pulmonale unmasking cardiopulmonary interactions in cardiogenic shock.
    J Electrocardiol. 2026;98:154409.
    

    >> Share

    
    
52. SETOGUCHI T, Matsumoto N, Matsunaga Y, Iwata R, et al
    Comparison between measured and synthesized posterior lead electrocardiograms during percutaneous coronary intervention-induced myocardial ischemia.
    J Electrocardiol. 2026;98:154419.
    

    >> Share

    
    
53. LI Y, Huang D, Pu Z, Lian J, et al
    Deep learning electrocardiogram analysis for rapid rule-out of acute coronary syndrome in the emergency department: a multicenter diagnostic accuracy study.
    J Electrocardiol. 2026;98:154420.
    

    >> Share

    
    

    
    J Nucl Med

54. HESS A, Strunk M, Willmann M, Ross TL, et al
    Molecular Imaging of Mechanisms of Impaired Cardiac Repair After Macrophage Depletion in Mice: A Longitudinal Multitracer Imaging Study.
    J Nucl Med. 2026;67:1460-1468.
    

    >> Share

    
    

    
    JAMA

55. 
    LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: Research Summary.
    JAMA. 2026 Aug 29:e2617421. doi: 10.1001/jama.2026.17421.
    

    >> Share

    
    
56. MONTALESCOT G, Ferrari E, Souteyrand G, Bouleti C, et al
    LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: The AMUNDSEN Randomized Clinical Trial.
    JAMA. 2026 Aug 29:e2617302. doi: 10.1001/jama.2026.17302.
    

    >> Share

    
    
57. RAY KK, Stevens CAT
    A Marathon, Not a Sprint-AMUNDSEN and LDL-C Lowering After Myocardial Infarction.
    JAMA. 2026 Aug 29. doi: 10.1001/jama.2026.16837.
    

    >> Share

    
    

    
    Lancet

58. THE LANCET
    Reimagining maternal cardiovascular health.
    Lancet. 2026;408:867.
    

    >> Share

    
    
59. PABON MA, Smith G, Sharma G, Catov J, et al
    Adverse pregnancy outcomes and long-term cardiovascular disease risk.
    Lancet. 2026;408:952-968.
    

    >> Share

    
    
60. BRAZILE TL, Conrad N, Bergman L, Gnanaraj JP, et al
    Cardiovascular disease in pregnancy: physiology, global burden, risk stratification, and opportunities in care.
    Lancet. 2026;408:935-951.
    

    >> Share

    
    
61. BOEDDINGHAUS J, Bima P, Crisanti L, Keller DI, et al
    Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial.
    Lancet. 2026 Aug 29:S0140-6736(26)01654-5. doi: 10.1016/S0140-6736(26)01654.
    

    >> Share

    
    
62. IBANEZ B
    Stopping beta-blockers long after myocardial infarction.
    Lancet. 2026 Aug 30:S0140-6736(26)01650-8. doi: 10.1016/S0140-6736(26)01650.
    

    >> Share

    
    
63. SILVAIN J, Choi KH, Monguillon V, Kang D, et al
    Discontinuation of beta-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.
    Lancet. 2026 Aug 30:S0140-6736(26)01426-1. doi: 10.1016/S0140-6736(26)01426.
    

    >> Share

    
    

    
    N Engl J Med

64. TAKAHASHI K, Kozuma K, Morino Y, Kashiwabara K, et al
    Aspirin Omission at the Time of Primary Percutaneous Coronary Intervention in STEMI.
    N Engl J Med. 2026 Aug 29. doi: 10.1056/NEJMoa2606997.
    

    >> Share

    
    
65. ZOUNGAS S, Wolfe R, Moran C, Nicholls SJ, et al
    Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults.
    N Engl J Med. 2026 Aug 29. doi: 10.1056/NEJMoa2607314.
    

    >> Share

    
    
66. BYRNE RA
    The Emerging Role of Treatment Policy Implementation Trials in Acute Coronary Syndrome.
    N Engl J Med. 2026 Aug 29. doi: 10.1056/NEJMe2610678.
    

    >> Share

    
    
67. GIBSON CM, Steg PG, Bahit MC, Al-Lamee R, et al
    Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event.
    N Engl J Med. 2026 Aug 29. doi: 10.1056/NEJMoa2608717.
    

    >> Share

    
    
68. OMEROVIC E, Koul S, Andersson J, Ponten J, et al
    Prasugrel versus Ticagrelor in Acute Coronary Syndromes.
    N Engl J Med. 2026 Aug 29. doi: 10.1056/NEJMoa2609057.
    

    >> Share

    
    
69. BISCAGLIA S, Erriquez A, Colaiori I, Hakeem A, et al
    Complete Revascularization Guided by Functional Coronary Angiography in STEMI.
    N Engl J Med. 2026 Aug 29. doi: 10.1056/NEJMoa2605373.
    

    >> Share

    
    
70. LEE KK, Wereski R, Lowe D, O'Brien R, et al
    Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain.
    N Engl J Med. 2026 Aug 29. doi: 10.1056/NEJMoa2608903.
    

    >> Share

    
    

    
    PLoS One

71. AARABI SS, Semnani F, Semnani K, Esmaeili S, et al
    Economic drivers and systemic disparities in invasive coronary angiography: Insights from a national claims database.
    PLoS One. 2026;21:e0356496.
    

    >> Share

    
    
72. TUERSUN T, Mijiti N, Wubulikasimu G, Maimaitiming A, et al
    Predictive value of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio for in-stent restenosis after drug-eluting stent implantation in patients with coronary heart disease.
    PLoS One. 2026;21:e0356478.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share